A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health

PfizerMillions of resolutions come with every New Year, many of which are to get healthy. But, there's a lot of confusion around what constitutes healthy nutrition, which is a key piece of the puzzle. Now, there's an easy and free solution to help make sound nutritional choices to help people keep their resolutions throughout the year. The makers of Centrum® multivitamins announce the launch of nutritionpossible.com, a new website that provides simple tools and personalized information to make confident nutritional and lifestyle choices.

"We know that navigating the supplement aisle can be confusing and choosing the right foods to make sure you're getting everything in your diet can be challenging," said Dr. Jeffrey Blumberg, a member of the external panel of advisors for nutritionpossible.com and a professor of nutrition at Tufts University. So, the website aims to make nutrition information easy to access and understand.

The site offers guided information through:

  • a unique self-assessment tool that provides a personalized recommendation based on your reported dietary intake and provides educational information as you answer each question
  • trusted content from both WebMD and Mayo Clinic
  • expert nutritional commentary from professionals in the field including Jeffrey Blumberg, Ph.D., FACN, FASN, CNS; Balz Frei, Ph.D.; Cynthia Sass, MPH, RD, MA, CSSD; and Elizabeth Ward, MS, RD
  • the opportunity to engage with other visitors by community building and activity challenges where visitors can collect badges once the challenges have been completed

As part of today's launch, the first 100,000 visitors who complete their personal assessment will receive a special high-value coupon for products to help them get started on making nutrition possible in their daily routine.

"Offering people a simple tool in a confusing landscape will help them be more confident in their decisions when it comes to proper nutrition," said Tiffany McLaud, U.S. franchise lead, dietary supplements, Pfizer Consumer Healthcare. "We heard directly from consumers that simplified and easy-access to nutritional information is what they are looking for and need. Being in the multivitamin business for 30 years and trusted by consumers, the Centrum team listened and developed this online resource to help people achieve their overall nutritional goals."

Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Most Popular Now

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Sat...

Pre-clinical success for a universal flu vaccine o…

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Co...

Imfinzi is the first immunotherapy to demonstrate …

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi durin...

Global survey reveals that physicians need more in…

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make inf...

In clinical trials, new antibody therapy controls …

Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers i...

Sandoz Healthcare Access Challenge #SandozHACk ret…

Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The #SandozHACk is a global co...

Novartis licenses three novel anti-infective progr…

Novartis announced today that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug cand...

The Nobel Prize in Physiology or Medicine 2018 was…

Cancer kills millions of people every year and is one of humanity's greatest health challenges. By stimulating the inherent ability of our immune system to attack tumor c...

Pfizer to award more than $3 million in grants to …

Pfizer Inc. today announced the recipients of the Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Breast Cancer Research Awards. Four grants tota...

FDA approves first treatment for advanced form of …

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squam...

DNA islands effective as 'anti-bacterial drones'

Genomic "islands" that evolved from viruses can be converted into "drones" that disable Staphylococcus aureus, bacteria that are often resistant to antibiotics and pose a...

FDA awards 12 grants to fund new clinical trials t…

The U.S. Food and Drug Administration today announced that it has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to...